Abstract B047: Pancreatic cancer model for drug development and personalized treatment: Progress of the Tumor Model and Drug Development Core (TMDDC) of CaRE2
Challenges with studies of patient-derived xenografts (PDX) to screen best agents for treatment include the prolonged growth time and the long follow-up for evaluation of tumor response. A liquid biopsy assay that might within days evaluate tumor response could revolutionize selection of cancer treatment regimens...